1. Introduction {#sec1}
===============

Orthostatic hypotension (OH) is a condition reflecting the impaired capability of the autonomic nervous system (ANS) to maintain blood pressure in an upright position. It is defined as a supine-to-standing drop in systolic blood pressure (SBP) by more than 20 mmHg or in diastolic blood pressure (DBP) by more than 10 mmHg.[@bib1] Patients with OH have a significantly increased stroke risk of over two-fold[@bib2], [@bib3] and a 50--100% increased mortality rate comparing with those without OH.[@bib3], [@bib4], [@bib5] The presence of OH is also linked to higher incidence of coronary heart disease and heart failure.[@bib2] The prevalence of OH is estimated to be up to 18.2% in patients over 65 years of age.[@bib6] There is a higher prevalence among patients with diabetes.[@bib7]

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with significantly increased morbidity and mortality.[@bib8] The prevalence of AF is estimated to be 6.1% in patients over 65 years of age.[@bib9] Several mechanisms play a role in the pathogenesis, including ANS dysregulation,[@bib10], [@bib11] altered autonomic tone in patients with obstructive sleep apnea,[@bib12] and hypertension.[@bib13] Hypertension, in particular, was found to be related to the occurrence of AF, suggesting a relationship between the [ANS](https://www.sciencedirect.com/topics/medicine-and-dentistry/dysautonomia){#intref0010} and AF. We hypothesized that individuals who have OH may be at an increased risk of AF. We performed a meta-analysis of observational studies reporting on the association between OH and AF.

2. Methods {#sec2}
==========

2.1. Search strategy {#sec2.1}
--------------------

Two investigators (J.K. and N.A.) independently searched for published studies indexed in MEDLINE and EMBASE databases from inception to November 2018 using a search strategy ([Fig. 1](#fig1){ref-type="fig"}) that included the terms 'atrial fibrillation', 'orthostatic hypotension', 'postural hypotension', and 'orthostatic intolerance.' Only English language publications were included. A manual search for additional pertinent studies and review articles using references from retrieved articles was also completed.Fig. 1Search methodology and selection process.Fig. 1

2.2. Study eligibility criteria {#sec2.2}
-------------------------------

Two main criteria were assessed for the inclusion of studies. The first criterion was a reported incidence of AF in patients with or without OH. The second was a reported relative risk, hazard ratio, odds ratio (OR), incidence ratio, and/or standardized incidence ratio with 95% confidence intervals (CIs) (or sufficient data for the calculation to be performed by a third party). Patients without OH were used as controls. Study eligibility was independently determined by two investigators (J.K. and N.A.). Differences were resolved by mutual consensus. The Newcastle--Ottawa quality assessment scale was used to evaluate each study in three domains: (1) recruitment and selection of the participants, (2) similarity and comparability between the groups, and (3) ascertainment of the outcome of interest among cohort studies.[@bib14]

2.3. Definitions {#sec2.3}
----------------

OH was defined slightly differently between studies regarding the timing between repeat blood pressure measurements ([Table 1](#tbl1){ref-type="table"}), but all were in agreement regarding change in SBP or DBP. AF was also defined slightly differently among studies but all involved an ICD code or Electrocardiogram (ECG) interpretation ([Table 1](#tbl1){ref-type="table"}).Table 1Studies characteristics.Table 1First authorAgarwalFedorowskiKoYasaYear2013201020182018CountryUSASwedenUSASwedenStudy typeProspective cohortProspective cohortRetrospective cohortProspective cohortParticipant descriptionMen and women aged 45--64 years from the Atherosclerosis Risk in Communities (ARIC) studyMen and women from Malmo, SwedenParticipants from the Framingham Heart Study Original cohortMen and women born between 1923 and 1945, 1950 respectivelyExclusion criteria-Missing or poor quality of BP data-Prevalent AF/atrial flutter from baseline-Underlying heart rhythm abnormality-Missing BP data-Prevalent AF-History of heart failure-Prevalent MI-Missing BP data-Preexisting AF-Cases with current prevalent CVS diseaseParticipants, N Total12,07132,628173630,528 OH6031987256504 Non-OH11,46830,641148030,024OH definitionSBP drop of ≥20 mmHg or DBP of ≥10 mmHg when changing position from supine to standingSBP drop of ≥20 mmHg or DBP of ≥10 mmHg within 3 min of changing position from supine to standingSBP drop of ≥20 mmHg or DBP of ≥10 mmHg within 2 min of changing position from supine to standingSBP drop of ≥20 mmHg or DBP of ≥10 mmHg within 3 min of changing position from supine to standingMean age (years)54.1 ± 5.745.6 ± 7.471.7 ± 6.558 ± 8Gender (male), N (%)5431 (45%)21,958 (67.3%)690 (39.8%)12,221 (40%)Follow-up time (years)Mean of 18Mean of 24Mean of 8.3Median of 15 ± 4AF diagnosisICD-9 code 427.31, 427.32, 427.3\
ICD-10 code I48ICD-9 code 427.3ECG from routine examinationICD-8 code 427.92\
ICD-9 code 427D\
ICD-10 code I48Participants developing AF, N (%) Total1438 (11.9%)2312 (7.1%)2242824 OH111 (18.4%)196 (9.6%)N/AN/A Non-OH1327 (11.6%)2116 (6.9%)N/AN/AOdd/hazard ratio (95% CI)Adjusted HR: 1.40 (1.15--1.71)Adjusted HR: 1.20 (1.01--1.41)Adjusted HR: 1.61 (1.17--2.20)Adjusted HR: 1.89 (1.48--2.41)Confounder adjustmentAge, gender, race, DM, BMI, heart rate, SBP, DBP, hypertension and antihypertensive medication, CHD, smoking status, alcohol consumptionAge, gender, BMI, SBP, DBP, DM, smoking, total cholesterolAge, gender, SBP, DBP, BMI, heart rate, hypertension and antihypertensive medication, smoking status, history of heart failure and MIAge, gender, BMI, SBP, antihypertensive medication, DM, smoking statusConclusion by authorOH is associated with higher AF incidenceOH predicts incidence of AFOH is associated increased risk of incident AFPatients with OH or syncope show higher incidence of CVS disease and mortalityNewcastle--Ottawa quality assessment8777[^1]

2.4. Data extraction {#sec2.4}
--------------------

A standardized data abstraction form was used to obtain information from each study, these included the title, name of the first author, year of study, year of publication, country of origin, number of participants, demographic data of participants, method used to identify cases and controls, method used to diagnose the outcomes of interest (AF), average duration of follow-up, adjusted and unadjusted risk ratios and their corresponding 95% CI, and list of confounders that were adjusted for in the multivariate analysis. To ensure accuracy, all investigators independently performed this data abstraction process. Any discrepancies were resolved by referring back to the original articles.

2.5. Statistical analysis {#sec2.5}
-------------------------

Meta-analysis of the combined data was performed using a random-effects, generic inverse-variance method of DerSimonian and Laird.[@bib15] The heterogeneity of effect size estimates across these studies was quantified using the I^2^ statistic and Q statistic. For the Q statistic, substantial heterogeneity was defined as *p* \< 0.10. The I^2^ statistic ranges in value from 0 to 100% (I^2^ \< 25% is interpreted as low heterogeneity; I^2^ = 25%--50%, moderate heterogeneity; and I^2^ \> 50%, substantial heterogeneity).[@bib16] A sequential exclusion strategy, as described by Patsopoulos et al,[@bib17] was used to examine whether overall estimates were influenced by the substantial heterogeneity observed. We sequentially and cumulatively excluded studies that accounted for the largest share of heterogeneity until I^2^ was less than 50%. We then examined whether relative risk estimates were consistent. In accordance with Cochrane, publication bias was assessed using funnel plot analysis. Funnel plot asymmetry was to be further confirmed with Egger\'s test if there were more than 10 available studies.[@bib18] All analyses were performed using Review manager version 5.3 and STATA version 14.1 (College Station, TX).

3. Results {#sec3}
==========

3.1. Description of included studies {#sec3.1}
------------------------------------

Our search strategy yielded 31 potentially relevant articles (19 articles from EMBASE and 12 articles from MEDLINE). After the exclusion of 10 duplicate articles, 21 articles underwent title and abstract review. Four studies were excluded at this stage because they were review articles (two) or case reports (two), leaving 17 articles for full-length article review. Ten studies were excluded as there was no outcome of interest. One study was excluded because analysis was performed only in a 'postprandial hypotension' group. One study examined the incidence of AF in the presence of OH only without a control group and was, therefore, eliminated. Finally, one study did not exclude patients with previously diagnosed AF from the cohort. In summary, three prospective cohort studies and one retrospective cohort study with and without OH patients were included in this meta-analysis. The clinical characteristics are described in [Table 1](#tbl1){ref-type="table"}.

3.2. Quality assessment of included studies {#sec3.2}
-------------------------------------------

The Newcastle--Ottawa scale (0--9) was used to evaluate included studies in 3 domains: (1) selection, (2) comparability, and (3) outcomes. Higher scores represent higher study quality. All studies received a score of 7--8, which reflect the inclusion of high quality studies. Detailed evaluation of each study is presented in a supplementary table ([Table S1](#appsec1){ref-type="sec"}).

3.3. Meta-analysis result {#sec3.3}
-------------------------

A total of four studies (3 prospective, 1 retrospective) with 76,963 participants were included in the meta-analysis. The prevalence of OH ranged from 1.6 to 12.9%. There was an association between OH and new-onset AF (OR 1.48; 95% CI \[1.21, 1.81\], *p* \< 0.001) with substantial heterogeneity (I^2^ = 69.4%) ([Fig. 2](#fig2){ref-type="fig"}a). Owing to substantial heterogeneity, we performed subgroup analyses by mean age, sex predominance, normotensive group, and hypertensive group to determine their impacts. In the subcategory for mean age, we further subdivided the group into a 'greater than 55 year-old' sample[@bib19], [@bib20] or a 'less than 55 year-old' sample.[@bib21], [@bib22] Both age subgroups revealed a strong association between new-onset AF and OH (OR 1.28; 95% CI \[1.11, 1.49\], p = 0.003 with I^2^ = 27.7% and OR 1.78; 95% CI \[1.48, 2.16\], p \< 0.001 with I^2^ = 0%, respectively) ([Fig. 2](#fig2){ref-type="fig"}b). In relation to sex, we found that both female and male groups exhibited a statistical association between OH and the incidence of new-onset AF (OR 1.60; 95% CI \[1.3, 1.94\], *p* \< 0.001 with I^2^ = 43.8% and OR 1.20; 95% CI \[1.02,1.42\], *p* \< 0.001). Given that there was only one study for the male group, heterogeneity could not be calculated ([Fig. 2](#fig2){ref-type="fig"}c).Fig. 2a) Forest plot of studies comparing new-onset AF in patients with and without OH. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using the random effects model. A diamond data marker represents the overall adjusted OR and 95% CI for the outcome of interest. (b) Forest plot of subgroup studies categorized by age (more than or less than 55 years old), comparing the occurrence of new-onset AF in patients with and without OH. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using the random effects model. A diamond data marker represents the overall adjusted OR and 95% CI for the outcome of interest. (c) Forest plot of subgroup studies categorized by sex, comparing the occurrence of new-onset AF in patients with and without OH. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using the random effects model. A diamond data marker represents the overall adjusted OR and 95% CI for the outcome of interest. (d) Forest plot of subgroup studies categorized as hypertensive or normotensive, comparing the occurrence of new-onset AF in patients with and without OH. Horizontal lines represent the 95% CIs with marker size reflecting the statistical weight of the study using the random-effects model. A diamond data marker represents the overall adjusted OR and 95% CI for the outcome of interest. AF, atrial fibrillation; OH, orthostatic hypotension; CI, confidence interval; OR, odds ratio.Fig. 2

Two studies provided conditional probabilities for new onset AF given OH (18.4% according to Agarwal and 9.6% according to Fedorowski). The probability of new onset AF for all comers was 11.9% in Agarwal and 7.1% in Feodowski. Through the application of Bayes' theorem, the posterior probability of OH given AF was estimated to be 7.7% and 8.2%, for Agarwal and Fedorowski, respectively. The marginal probability of OH was 5% and 6.1%, respectively.

In hypertensive patients,[@bib20], [@bib21], [@bib22] analysis revealed an association between OH and the occurrence of new-onset AF (OR 1.46; 95% CI \[1.27, 1.68\], *p* \< 0.001 with I^2^ = 0). Conversely, in normotensive patients,[@bib21], [@bib22] the correlation between OH and new-onset AF was not statistically significant (OR 1.14; 95% CI \[0.84, 1.53\] with I^2^ = 43%) ([Fig. 2](#fig2){ref-type="fig"}d). Funnel plot analysis did not suggest publication bias ([Fig. 3](#fig3){ref-type="fig"}). Egger\'s test was ultimately not performed due to an insufficient number of studies included in the meta-analysis. Sensitivity analysis performed to explore heterogeneity showed no significant change in the findings when each study was separately omitted.Fig. 3Funnel plot of OH and new-onset AF. Circles represent published studies.AF, atrial fibrillation; OH, orthostatic hypotension.Fig. 3

4. Discussion {#sec4}
=============

OH is notoriously associated with higher morbidity and mortality. Several observational studies have suggested that patients with OH are susceptible to adverse cardiac events.[@bib4], [@bib5], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27] It was also associated with a higher risk of falls, especially in elderly patients.[@bib7], [@bib28], [@bib29] Additionally, OH is associated with new-onset AF, one of the most common cardiac arrhythmias[@bib9] contributing to adverse outcomes.[@bib30], [@bib31], [@bib32]

Our meta-analysis demonstrated that the presence of OH was associated with new-onset AF up to 1.5-fold. In addition, our subgroup analyses all consistently correlated OH with AF. The prevalence of OH in our study ranged from 1.6 to 12.9%, due to lower mean subject age. However, the incidence of AF approached figures reported in the literature.

Given substantial heterogeneity in our study, we conducted subgroup analyses to evaluate for possible confounding factors. We suspected age, sex predominance, or blood pressure status (normotensive or hypertensive) might explain such findings. Regarding age, the group with patients 55 years or older had a higher risk than the group with patients younger than 55 years (OR 1.78 versus 1.28, respectively). This finding was consistent with previous studies, which determined that the prevalence and incidence of AF increased with age.[@bib9], [@bib33], [@bib34], [@bib35] Surprisingly, our subgroup analysis suggested that female sex was more associated with new-onset AF than male sex (OR 1.61 versus 1.20, respectively). This finding appears to contradict the fact that female sex was, in general, found to be protective against AF.[@bib9] However, it may reflect a lack of sensitivity in the meta-analysis given that only one study included a male sex arm.[@bib22] Considering the exclusion criteria and demographic data, all patients with a previous myocardial infarction (MI) and history of heart failure were not included and the mean age was 45 which was the lowest mean when compared with other studies. These factors might explain the higher rate of new-onset AF in the female sex subgroup and the lower prevalence of OH than that previously reported in those older than 65 years of age.

Considering methodological aspects, despite similar OH definitions among studies, the interval between blood pressure recordings after position changes was divergent, likely confounding overall results in this analysis. In addition, the inclusion and exclusion criteria, demographical data, comorbidity, and mean duration of follow-up were totally different. These factors are thought to be a substantial source of errors in our study, contributing to significant heterogeneity. Thus, one should interpret the results cautiously as diverse methods among the studies exist.

We found a statistical correlation between OH and new-onset AF in hypertensive patients but not normotensive patients. We suspect two reasons for this result. First, only two studies provided enough data to abstract for analysis, which may have resulted in insufficient power. Second, participants from Fedorowski et al[@bib22] seemed healthier, and thus, our subgroup analysis is likely to be affected by this fact. Hence, this may justify further study to evaluate the effect of OH in the setting of normotensive status.

The link between OH and new-onset AF has remained elusive. Several mechanisms have been proposed but are yet to be verified. In general, blood pressure control following postural change is regulated by the sympathetic and parasympathetic nervous system, which are collectively referred to as the ANS.[@bib36] To start, the pathogenesis for OH is thought to be secondary to an impaired ANS. It is believed that ANS dysregulation may play a role in the pathogenesis of AF as well, by impairing neurohormonal signal transmission and modulation in the heart thereby precipitating AF.[@bib37], [@bib38] This mechanism implies that OH may be a harbinger for developing AF.

Many conditions are associated with OH including advancing age,[@bib39], [@bib40] structural heart disease such as aortic stenosis,[@bib41] chronic heart failure,[@bib22] diabetes,[@bib42] and hypertension,[@bib43], [@bib44]; all of which are known AF risk factors. Thus, the presence of OH may serve to raise the suspicion for these underlying comorbidities which are often related to AF. Of note, abnormal diurnal BP variation[@bib45] as well as supine hypertension,[@bib46] commonly found in OH patients, may instigate periodic increases in afterload leading to end-organ damage[@bib47], [@bib48], [@bib49] such as left ventricular hypertrophy and renal impairment.[@bib50] As a result, either MI[@bib51], [@bib52] or CHF may develop and AF may follow given the high risk of these conditions.[@bib53] In other words, OH may indirectly induce AF through other related processes.

In addition, ANS dysregulation may result in arterial stiffness[@bib54] which may consequently lead to both OH and AF.[@bib55], [@bib56] One study showed that restoration of sinus rhythm from AF improved baroreceptor reflex impairment, a proposed mechanism for the pathogenesis of OH.[@bib36] This finding further supports the association between AF and OH and suggests that the interplay between AF and OH may be bidirectional.

4.1. Limitations {#sec4.1}
----------------

There are a number of limitations with our meta-analysis. First, there is substantial heterogeneity in our study which is a major limitation. This is likely due to the included studies which were all observational in nature, with different methodologies, demographic data, and heterogeneous comorbidities. Hence, the influence of residual confounders could not be completely excluded. Second, it is possible that AF was underdetected given the methods used to detect the incidence of AF in each study. For instance, paroxysmal AF could be easily missed. Third, we did not perform subgroup analyses of OH subcategories including initial OH and delayed OH because of insufficient data. In addition, the subtype of OH such as neurogenic OH was not separately investigated. Each OH subtype may produce different conditional probabilities and posterior probabilities for AF. Fourth, OH documentation in all studies was determined at the first visit leading to a possible underestimate of the prevalence. Finally, only four studies were included in our analysis. Despite a seemingly symmetrical funnel plot, the possibility of false negative test could not be excluded as a small number of studies were included, resulting in reduced sensitivity of such an analysis. Nevertheless, we believe the number of recruited participants were substantial enough to yield meaningful results.

5. Conclusion {#sec5}
=============

In summary, the presence of OH is associated with new-onset AF. Our meta-analysis revealed a clear association between OH and AF as evidenced by ORs of up to 1.5. The association appears to be bidirectional, given multiple proposed mechanisms and supporting evidence from other studies involving dysregulation of the ANS, baroceptor impairment in AF, and comorbidities such as CHF and MI which may themselves be a result of OH. However, our results favor OH as a predisposing risk factor for the development of AF. Thus, addressing autonomic instability may serve to reduce the prevalence and incidence of OH as well as the incidence of AF. Certainly, further studies are warranted in the future clarifying the relationship between OH and AF and determining causation.
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[^1]: AF, atrial fibrillation; BP, blood pressure; BMI, body mass index; CHD, coronary heart disease; CVS, cardiovascular; DBP, diastolic blood pressure; DM, diabetes mellitus; HR, hazard ratio; MI, myocardial infarction; OH, orthostatic hypotension; SBP, systolic blood pressure; CI, confidence interval; OR, odds ratio.
